. Thus CSF, in contrast to plasma (Samuelsson, 1972) , might be expected to contain measurable levels of PG. Several studies (White et al., 1971; Denton et al., 1972; Pelofsky et al., 1972; Yamamoto et al., 1972; Nakano et al., 1973; Greenberg et al., 1974; La Torre et al., 1974) have shown that some of them such as PG F2 alpha are potent vasoconstrictor agents on cerebral arteries, while PG of the E type are vasodilators. Cerebrovascular events are followed by the liberation of different vasoactive agents (Wurtman and Zervas, 1974; Lavyne et al., 1975) . In our study we found a positive correlation between PG E2 levels in CSF and the severity of a stroke.
Prostaglandins (PG) which have different biological activities have been identified in human brain (Holmes and Horton, 1968; Pennink et al., 1972) . Data available at present indicate that PG synthesised in brain in vivo appear in the cerebrospinal fluid, are activately taken up by the choroid plexus and transported into the venous circulation and removed by extra-neuronal tissues (Bito, 1972a,b) . Thus CSF, in contrast to plasma (Samuelsson, 1972) , might be expected to contain measurable levels of PG. Several studies (White et al., 1971; Denton et al., 1972; Pelofsky et al., 1972; Yamamoto et al., 1972; Nakano et al., 1973; Greenberg et al., 1974; La Torre et al., 1974) have shown that some of them such as PG F2 alpha are potent vasoconstrictor agents on cerebral arteries, while PG of the E type are vasodilators. Cerebrovascular events are followed by the liberation of different vasoactive agents (Wurtman and Zervas, 1974; Lavyne et al., 1975) . In our study we found a positive correlation between PG E2 levels in CSF and the severity of a stroke.
Patients and methods
Sixteen patients suffering from suspected cerebral vascular events were admitted to Ichilov Hospital at random for clinical investigation. The clinical characteristics of the patients and findings of the investigations are summarised in (Bauminger et al., 1973) . No drugs with known anti-PG activities were added to the treatment. The patients were treated only with Hartmann (Ringer lactate) solution and glucose 5%. Manitol and diuretics were used when necessary.
The patients were classified into two groups: (a) mild to moderate cerebrovascular accidentpatients who suffered from paresis which improved during one month (five patients), and (b) moderate to severe cerebrovascular accident-patients who developed changes of consciousness and paralysis that did not improve enough during the first month (11 patients of whom five died).
The patients were followed up after the cerebrovascular event for nine to 12 months.
Results
The PG E2 levels in CSF, summarised in Table 2. R. L. Carasso, J. Vardi, J. M. Rabay, U. Zor, and M. Streifler Measurements of prostaglandin E2 in cerebrospinal fluid in patients sufjering from stroke by inhibition of platelet aggregation and by a local vasodilator effect (Nakano et al., 1972) . These two biological actions may contribute to the increased hyperaemia described as the 'luxury perfusion syndrome' (H0edt-Rasmussen et al., 1967; Paulson et al., 1970) Figure 
